Managed Account Advisors’s Abiomed Inc ABMD Stock Holding History

Managed Account Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.63M	Buy	85,601 +20,237	+31%	+$1.34M	﹤0.01%	1366
2015 Q1	$4.68M	Buy	65,364 +11,225	+21%	+$609K	﹤0.01%	1458
2014 Q4	$2.06M	Sell	54,139 -13,213	-20%	-$417K	﹤0.01%	1805
2014 Q3	$1.67M	Buy	67,352 +33,743	+100%	+$855K	﹤0.01%	1877
2014 Q2	$845K	Buy	33,609 +13,938	+71%	+$324K	﹤0.01%	2047
2014 Q1	$512K	Buy	19,671 +5,676	+41%	+$157K	﹤0.01%	2097
2013 Q4	$374K	Buy	+13,995	New	+$346K	﹤0.01%	2110

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Managed Account Advisors's ABMD Position: Q2 2015 in Review

Managed Account Advisors increased its Abiomed Inc (ABMD) stake by 31% in Q2 2015, buying an estimated $1.34M and bringing the position to 85,601 shares worth $5.63M. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Managed Account Advisors first reported a position in ABMD in Q4 2013 and has held it in 7 quarters since. 227 funds tracked by Wall St. Rank hold ABMD as of Q2 2015.

Managed Account Advisors held 85,601 shares of Abiomed Inc worth $5.63M as of Q2 2015.
Managed Account Advisors bought 20,237 Abiomed Inc shares in Q2 2015, an estimated $1.34M.
Abiomed Inc made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1366 holding.
Managed Account Advisors first reported a position in Abiomed Inc in Q4 2013 and has held it in 7 quarters since.
227 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.